|
ZNF665 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.460400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.779220E-01 |
| Normal-vs-Stage2 |
7.621200E-01 |
| Normal-vs-Stage3 |
2.183000E-01 |
| Normal-vs-Stage4 |
3.610300E-02 |
| Stage1-vs-Stage2 |
6.820400E-01 |
| Stage1-vs-Stage3 |
8.046000E-01 |
| Stage1-vs-Stage4 |
2.571200E-01 |
| Stage2-vs-Stage3 |
6.169600E-01 |
| Stage2-vs-Stage4 |
2.967600E-01 |
| Stage3-vs-Stage4 |
3.353000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.164400E-01 |
| Normal-vs-AfricanAmerican |
3.824000E-01 |
| Normal-vs-Asian |
5.782400E-02 |
| Caucasian-vs-AfricanAmerican |
7.178000E-01 |
| Caucasian-vs-Asian |
3.386800E-01 |
| AfricanAmerican-vs-Asian |
3.464000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.390440E-01 |
| Normal-vs-Female |
3.961600E-01 |
| Male-vs-Female |
4.228000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.498800E-01 |
| Normal-vs-Extreme_Weight |
3.344500E-02 |
| Normal-vs-Obese |
7.888400E-01 |
| Normal-vs-Extreme_Obese |
1.429800E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.788600E-01 |
| Normal_Weight-vs-Obese |
3.944800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.575450E-01 |
| Extreme_Weight-vs-Obese |
6.289800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.740200E-01 |
| Obese-vs-Extreme_Obese |
3.130300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.074000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.469400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.788800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.056200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.395000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.017000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.471760E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.998400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.071840E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.580000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.785000E-01 |
| Normal-VS-Type2 PRCC |
2.158500E-02 |
| Normal-VS-KIRP CIMP |
6.466600E-01 |
| Normal-VS-Unclassified PRCC |
6.989600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.836400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.775800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.917200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.489400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.390100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.313200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.545900E-02 |
| Normal-vs-N1 |
8.093200E-01 |
| Normal-vs-N2 |
2.9393154576951E-12 |
| N0-vs-N1 |
2.636800E-01 |
| N0-vs-N2 |
5.8305027472727E-11 |
| N1-vs-N2 |
1.498690E-03 |
|
|
